Androgens are hormones that control the development of male sexual characteristics. The most powerful of the androgens is called ...

Pfizer’s Talzenna in combi with Xtandi improves survival outcomes in metastatic castration resistant prostate cancer: New York Saturday, February 15, 2025, 11:00 Hrs [IST] Pfize ...

Masturbation remains taboo – some people consider it an unnatural act because it has no reproductive purpose. This negative ...

One of the UK's most senior radiotherapy experts has spoken publicly for the first time about living with incurable cancer.Professor Adrian Crellin ...

Today, the National Sleep Foundation (NSF) announced Sleep Awareness Week® 2025 will take place from March 9-15. Sleep Awareness Week, now in its 27th year, is the NSF's annual campaign emphasizing ...

covering a variety of urologic issues such as prostate cancer, male contraception ... catheters by allowing the tube to ...

Clinical Progression of Prostate Cancer from Active Surveillance is Predicted by Decipher® Genomic Classifier Score on Index Biopsy Independent from Risk Assessment by MRI Characteristics SUO 2024: AI ...

mevrometostat (PF-06821497) is under development for the treatment of relapsed or refractory, follicular lymphoma, prostate cancer, metastatic hormone refractory (castration-resistant, ...

We evaluated the effect of FKA on prostate tumor ... lineages of cancer cells for the initiation and maintenance of prostatic neoplastic lesions (3). Increasing evidence indicates that CSCs contribute ...

Prostate-specific antigen responses were similar between transdermal estradiol and hormone therapy combined with androgen receptor inhibitors in prostate cancer.